US 12364745
Immunogenicity of a CpG-adjuvanted recombinant plague vaccine
granted A61KA61K2039/545A61K2039/55505
Quick answer
US patent 12364745 (Immunogenicity of a CpG-adjuvanted recombinant plague vaccine) held by The Government of the United States, as represented by the Secretary of the Army expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Government of the United States, as represented by the Secretary of the Army
- Grant date
- Tue Jul 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2039/545, A61K2039/55505, A61K2039/55561, A61K2039/575